Trials / Completed
CompletedNCT00759148
Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,179 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 1 Month
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of Moxifloxacin AF Ophthalmic Solution compared to Moxifloxacin AF Vehicle in the treatment of bacterial conjunctivitis in patients one month of age or older.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Moxifloxacin Alternative Formulation (AF) Ophthalmic Solution 0.5% | Eye drops |
| OTHER | Moxifloxacin AF Vehicle | Inactive ingredients used as a placebo for masking purposes |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2008-09-25
- Last updated
- 2018-01-02
- Results posted
- 2011-03-22
Source: ClinicalTrials.gov record NCT00759148. Inclusion in this directory is not an endorsement.